Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation

En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
p p Read More

The US sees around 476,000 new Lyme cases every year

February 3, 2026 En Carta Diagnostics, FDA, Lyme disease, News

ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children

ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
p p Read More

Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys

February 2, 2026 ALK, anaphylaxis, EURneffy, News

CERo reports encouraging early data from phase 1 trial of CER‑1236

CERo reports encouraging early data from phase 1 trial of CER‑1236
p p Read More

CER‑T therapy shows initial safety signals and prompts protocol expansion

January 29, 2026 News

ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray

ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
p p Read More

Trial to assess whether once‑weekly treatment can reduce symptomatic viral respiratory infections

January 29, 2026 News

Argo Biopharma doses first patient in phase 2b trial of BW‑20829

siRNA therapeutic progresses in global study for patients with elevated Lp(a)

January 29, 2026 News

Akari files new patent and advances second ADC targeting CEACAM5

Akari files new patent and advances second ADC targeting CEACAM5
p p Read More

Company strengthens pipeline with AKTX-102 as it broadens its intellectual property estate

January 29, 2026 News

BioMed X launches kidney disease project in partnership with the government of Barbados

BioMed X launches kidney disease project in partnership with the government of Barbados
p p Read More

Initiative focuses on population-specific molecular profiling

January 28, 2026 News

Gedeon Richter UK takes over UK rights to cariprazine

Gedeon Richter UK takes over UK rights to cariprazine
p p Read More

Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati

January 28, 2026 News

Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention

Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
p p Read More

Dawnzera showed an 81% reduction in the four-weekly rate of HAE attacks compared to placebo

January 26, 2026 hereditary angioedema, News, Otsuka Pharmaceutical

Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer

Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
p p Read More

Ovarian cancer is the fifth leading cause of deaths from cancer in women

January 26, 2026 Corcept Therapeutics, News, Oncology, Ovarian Cancer

Posts navigation

Posts pagination

« Previous 1 … 5 6 7 … 84 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy